Speaker illustration

Professor Gary Tse

Hong Kong Metropolitan University, Hong Kong (China)

Member of:

European Society of Cardiology

Qualifications: BA (Hons.) (Cantab.), MBBS (Imperial), MA (Cantab.), MPH (Manc.), MD (Cantab.) PhD (Cantab.), MFPH (UK), FESC, FACC, FSCAI, FHRS, FRCP (Glasg, Edin, Lond), FRCPCH, FFPH Prof. Tse established the Laboratory of Cardiovascular Physiology, Cardiovascular Analytics Group and International Health Informatics Study Network for pre-clinical, clinical and meta-analysis research, respectively, in China. He was appointed to a Distinguished Professorship at the Tianjin Institute of Cardiology in 2019. He holds a joint appointment as Reader in Public Health at the Kent and Medway Medical School, Public Health Physician at the Public Health Directorate of Medical Council (2021), and Senior Epidemiologist at the Observational and Pragmatic Research Institute, Singapore and Optimum Patient Care, Cambridge (2020), UK. He is Visiting Professor to the Faculty of Health and Medical Sciences, University of Surrey (2020), and Honorary Associate Professor, UCL (2022).

Diabetic ketoacidosis in patients with type 2 diabetes mellitus receiving sodium-glucose co-transporter-2 inhibitors: The Hong Kong Diabetes Study

Event: ESC Preventive Cardiology 2024

Topic: Antidiabetic Pharmacotherapy

Session: Effectively managing cardiovascular risk in Type 2 diabetes

Thumbnail

PowerAI-CVD: Chinese-specific artificial intelligence-powered predictive model for cardiovascular disease

Event: ESC Preventive Cardiology 2024

Topic: Scores

Session: Enlisting AI for risk stratification

Thumbnail

Association between brachial-ankle pulse wave velocity and new-onset atrial fibrillation: A report from Kailuan Study

Event: ESC Congress 2023

Topic: Prevention

Session: Predictors for atrial fibrillation

Thumbnail

Association between psychological distress and cardiovascular health amongst cancer survivors in the United States: findings from nationally representative data

Event: ESC Congress 2023

Topic: Public Health

Session: Innovations in public health and health economics (4)

Thumbnail

Lower risks of sodium glucose cotransporter 2 (SGLT2) inhibitors compared to dipeptidyl peptidase-4 (DPP4) inhibitors for new-onset hip fracture risks in patients with type-2 diabetes: A propensity sc

Event: ESC Congress 2023

Topic: Antidiabetic Pharmacotherapy

Session: Antidiabetic medications and cardiovascular disease

Thumbnail

Association between immune checkpoint inhibitors and heart failure hospitalizations: a population-based self-controlled case series

Event: ESC Congress 2023

Topic: Cardiotoxicity of Drugs and Other Therapies

Session: Cardiotoxicity of cancer therapies

Thumbnail

Interpretable machine learning model using Extreme Gradient Boosting with Nonnegative Matrix Factorization improves the accuracy of arrhythmic risk prediction in Brugada Syndrome

Event: ESC Congress 2023

Topic: Ion Channel Disorders

Session: Ion channel diseases: risk stratification and treatment

Thumbnail

Cardiac abnormalities after induction of endoplasmic reticulum stress are associated with mitochondrial dysfunction and connexin43 expression

Event: ESC Congress 2019

Topic: Cardiotoxicity of Drugs and Other Therapies

Session: Basic science heart failure

Thumbnail

Pioglitazone inhibits diabetes-induced atrial mitochondrial oxidative stress and improves mitochondrial biogenesis, dynamics and function through the PGC-1 signaling pathway

Event: ESC Congress 2019

Topic: Atrial Stressors

Session: Atrial fibrillation pathophysiology and mechanisms

Thumbnail

Catheter ablation for atrial fibrillation in heart failure patients: a systematic review and meta-analysis of randomized controlled trials

Event: ESC Congress 2018

Topic: Catheter Ablation of Arrhythmias

Session: Atrial fibrillation ablation

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb